Compugen Ltd. - Ordinary Shares (CGEN): Price and Financial Metrics

Compugen Ltd. - Ordinary Shares (CGEN): $0.93

0.05 (+5.68%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add CGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#74 of 356

in industry

CGEN Price/Volume Stats

Current price $0.93 52-week high $1.49
Prev. close $0.88 52-week low $0.51
Day low $0.87 Volume 64,500
Day high $0.93 Avg. volume 405,805
50-day MA $1.07 Dividend yield N/A
200-day MA $0.92 Market Cap 80.56M

CGEN Stock Price Chart Interactive Chart >


Compugen Ltd. - Ordinary Shares (CGEN) Company Bio


Compugen Ltd. engages in the research, development, and commercialization of therapeutic and product candidates primarily in the United States, Europe, and Israel. The company was founded in 1993 and is headquartered in Tel Aviv, Israel.


CGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

CGEN Latest Social Stream


Loading social stream, please wait...

View Full CGEN Social Stream

Latest CGEN News From Around the Web

Below are the latest news stories about COMPUGEN LTD that investors may wish to consider to help them evaluate CGEN as an investment opportunity.

Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?

Here is how Aspira (AWH) and Compugen (CGEN) have performed compared to their sector so far this year.

Yahoo | September 14, 2023

Compugen to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will present virtually at the H.C. Wainwright 25th Annual Global Investment Conference. The presentation will be available on demand on the Investor Relations section of Compugen's website at www.cgen.com from Monday, September 11, 2023, 7:00 AM ET for 30 days.

Yahoo | August 31, 2023

Has Compugen (CGEN) Outpaced Other Medical Stocks This Year?

Here is how Compugen (CGEN) and Corcept Therapeutics (CORT) have performed compared to their sector so far this year.

Yahoo | August 29, 2023

Compugen Ltd. (NASDAQ:CGEN) Q2 2023 Earnings Call Transcript

Compugen Ltd. (NASDAQ:CGEN) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen’s Second Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. As a reminder, today’s call is being recorded. An audio webcast of this call will […]

Yahoo | August 10, 2023

Compugen Reports Second Quarter 2023 Results

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced financial results for the second quarter ended June 30, 2023 and provided a corporate update on key events since the start of 2023.

Yahoo | August 7, 2023

Read More 'CGEN' Stories Here

CGEN Price Returns

1-mo -18.42%
3-mo -18.42%
6-mo 38.81%
1-year 41.55%
3-year -94.28%
5-year -74.17%
YTD 29.94%
2022 -83.36%
2021 -64.49%
2020 103.19%
2019 174.65%
2018 -13.20%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!